FP07.06 Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront.
F. Blanc-Durand,X. Mielgo Rubio,E. Auclin, S. Ponce-Aix,R. Lopez Castro,E. Nadal, D. Planchard,B. Routy,L. Hendriks,I. Sullivan,N. Dempsey,S. Pilotto,F. Aboubakar,D.J. Pinato, M. Castonguay,A. Rodriguez, A. Amores, M.V. Bluthgen, B. Duchemann, P. Cruz Castellano,C. Aguado De La Rosa,M. Sereno Moyano, J. Ruffinelli,G. Lopez,C. Caramella,B. Besse,L. Mezquita Journal of Thoracic Oncology（2021）
关键词
NSCLC, Immunotherapy, biomarker
AI 理解论文
溯源树
样例
